The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I have also put a call in to the company only to be directed to voicemail. I left a message for Hannah asking for a call back. Chances of getting one??
Nasdaq listing only is also my interpretation, communication from this company always leaves a lot to be desired, WHY ?
As the Accustem D-merger was agreed in court I believe that the bods will have to follow the wording set out in the court case, therefore, list on LSE and NAS.
Anyone got the court case wording which I assume was RNS'd.
I need to flit back through the Rns's now as only just seen this one.
vbw
stims thats how i see it too, have tried to call the company to clarify but with no joy.
US listing only is my interpretation of that RNS which is is fine by me.
Just be glad to get it over and done with! Only takes a few mins to sign W-8BEN from with HL if you haven't already done so.
Plan,
Appreciate your comment. I actually filled out the form months ago with HL so I would hopefully be okay if it was only a nadaq listing; however, I'm relatively confident that the shares will be listed on the LSE.
If I'm not mistaken some ISA's dont allow foreign trading. Possibly barclays? Either way, I expect its all a miss understanding and no one has anything to worry about!
Original RNS
"It is intended that Accustem will seek admission to the standard segment of the Official List and admission to trading on the London Stock Exchange plc by way of an IPO in late Q4 2020 ("Accustem Admission") and POTENTIALLY a dual listing on NASDAQ in 2021."
I guess today is a confirmation of the dual listing and removing doubt of the potential/want to dual list
IF they weren’t now intending to list on LSE they would have said that - it could however have been composed a bit better for absolute clarity as doesn’t read well on first glance.
So fantastic we now have Accustem on LSE and NASDAQ - bring it on!
IMHO DYOR GLA
Any idea what it's worth? Will it be 1p, 10, £1 a share?.
Hi Levs,
I am with ii and I can hold foreign shares in both my ISA and SIPP, you just need to fill in some US tax type forms saying you are a private investor. There are no rules stopping you holding foreign shares in your ISA but it will depend on who you trade with.
Regards,
NEW YORK and LONDON, April 13, 2021 - Tiziana Life Sciences plc (NASDAQ: TLSA; LSE: TILS), today announced that its former subsidiary, Accustem Sciences Limited ("Accustem"), intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences plc shareholders.
"SHORTLY AFTER COMPLETION OF THE DISTRIBUTION OF SHARES......" So they list on NASDAQ AFTER LSE.
If listed on NASDAQ only?
Doesn't this have implications for those of us trading via ISA's ?